Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001477932-26-003587
Filing Date
2026-06-02
Accepted
2026-06-02 16:21:40
Documents
8
Period of Report
2026-07-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A vnrx_def14a.htm DEF 14A 798758
2 vnrx_def14aimg100.jpg GRAPHIC 27217
3 vnrx_def14aimg101.jpg GRAPHIC 151277
4 vnrx_def14aimg102.jpg GRAPHIC 199994
5 vnrx_def14aimg103.jpg GRAPHIC 140932
6 vnrx_def14aimg104.jpg GRAPHIC 108472
7 vnrx_def14aimg98.jpg GRAPHIC 23721
8 vnrx_def14aimg99.jpg GRAPHIC 31393
  Complete submission text file 0001477932-26-003587.txt   1741380
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (512) 774-8930
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36833 | Film No.: 261056361
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)